Marshall Financial Group (Maryland)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Sell |
3,932
-980
| -20% | -$67.9K | 0.05% | 217 |
|
|
2025
Q1 | $341K | Sell |
4,912
-1,373
| -22% | -$95.3K | 0.07% | 183 |
|
|
2024
Q4 | $541K | Sell |
6,285
-7,228
| -53% | -$622K | 0.13% | 148 |
|
|
2024
Q3 | $1.61M | Hold |
13,513
| – | – | 0.38% | 62 |
|
|
2024
Q2 | $1.93M | Sell |
13,513
-440
| -3% | -$62.8K | 0.54% | 45 |
|
|
2024
Q1 | $1.79M | Buy |
13,953
+702
| +5% | +$90.1K | 0.52% | 55 |
|
|
2023
Q4 | $1.37M | Sell |
13,251
-654
| -5% | -$67.7K | 0.44% | 59 |
|
|
2023
Q3 | $1.26M | Sell |
13,905
-171
| -1% | -$15.6K | 0.46% | 57 |
|
|
2023
Q2 | $1.14M | Buy |
14,076
+164
| +1% | +$13.3K | 0.39% | 63 |
|
|
2023
Q1 | $1.11M | Sell |
13,912
-6,040
| -30% | -$481K | 0.4% | 58 |
|
|
2022
Q4 | $1.35M | Sell |
19,952
-176
| -0.9% | -$11.9K | 0.52% | 59 |
|
|
2022
Q3 | $1M | Sell |
20,128
-158
| -0.8% | -$7.87K | 0.42% | 65 |
|
|
2022
Q2 | $1.13M | Sell |
20,286
-4,280
| -17% | -$238K | 0.45% | 62 |
|
|
2022
Q1 | $1.36M | Buy |
24,566
+94
| +0.4% | +$5.22K | 0.56% | 52 |
|
|
2021
Q4 | $1.37M | Sell |
24,472
-2,912
| -11% | -$163K | 0.5% | 61 |
|
|
2021
Q3 | $1.32M | Buy |
27,384
+790
| +3% | +$37.9K | 0.68% | 35 |
|
|
2021
Q2 | $1.11M | Sell |
26,594
-2,662
| -9% | -$112K | 0.6% | 45 |
|
|
2021
Q1 | $986K | Buy |
29,256
+1,610
| +6% | +$54.3K | 0.59% | 71 |
|
|
2020
Q4 | $966K | Buy |
+27,646
| New | +$966K | 0.63% | 66 |
|